KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elanco Animal Health (ELAN) Current Assets (2017 - 2026)

Elanco Animal Health's Current Assets history spans 9 years, with the latest figure at $3.5 billion for Q4 2025.

  • On a quarterly basis, Current Assets rose 7.56% to $3.5 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $3.5 billion, a 7.56% increase, with the full-year FY2025 number at $3.5 billion, up 7.56% from a year prior.
  • Current Assets hit $3.5 billion in Q4 2025 for Elanco Animal Health, down from $3.5 billion in the prior quarter.
  • Over the last five years, Current Assets for ELAN hit a ceiling of $4.0 billion in Q1 2024 and a floor of $3.2 billion in Q3 2022.
  • Historically, Current Assets has averaged $3.4 billion across 5 years, with a median of $3.4 billion in 2021.
  • Biggest five-year swings in Current Assets: grew 14.15% in 2024 and later dropped 15.06% in 2025.
  • Tracing ELAN's Current Assets over 5 years: stood at $3.3 billion in 2021, then rose by 0.15% to $3.3 billion in 2022, then rose by 3.9% to $3.4 billion in 2023, then decreased by 5.64% to $3.2 billion in 2024, then grew by 7.56% to $3.5 billion in 2025.
  • Business Quant data shows Current Assets for ELAN at $3.5 billion in Q4 2025, $3.5 billion in Q3 2025, and $3.6 billion in Q2 2025.